Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Lantern Pharma Inc |
8/12 | 3,850 USD
+2,67% |
+2,67% |
|
Lantheus Holdings Inc |
9/12 | 60,880 USD
-2,23% |
-2,23% |
|
Larimar Therapeutics Inc |
8/12 | 3,820 USD
+3,24% |
+3,24% |
|
Leap Therapeutics Inc |
5/12 | 1,110 USD
-12,60% |
-12,60% |
|
Legend Biotech Corp |
9/12 | 23,880 USD
-8,58% |
-8,58% |
|
Lemaitre Vascular Inc |
9/12 | 82,850 USD
-0,10% |
-0,10% |
|
LENSAR Inc |
8/12 | 11,190 USD
-0,09% |
-0,09% |
|
Lexicon Pharmaceuticals Inc |
9/12 | 1,310 USD
-5,76% |
-5,76% |
|
Lifevantage Corporation |
9/12 | 6,570 USD
-0,61% |
-0,61% |
|
Ligand Pharmaceuticals, Inc. |
9/12 | 185,830 USD
+0,63% |
+0,63% |
|
Lineage Cell Therapeutics Inc |
8/12 | 1,690 USD
-1,74% |
-1,74% |
|
Lipocine Inc |
8/12 | 3,270 USD
+3,81% |
+3,81% |
|
Liquidia Corp |
8/12 | 35,010 USD
+1,74% |
+1,74% |
|
LivaNova PLC |
9/12 | 62,010 USD
-1,05% |
-1,05% |
|
Lixte Biotechnology Holdings Inc |
8/12 | 4,340 USD
+7,16% |
+7,16% |
Lumibird |
9/12 | 21,200 EUR
+4,95% |
+4,95% |
|
Lyra Therapeutics Inc |
8/12 | 3,970 USD
-7,03% |
-7,03% |